tiprankstipranks
Trending News
More News >
Upexi (UPXI)
NASDAQ:UPXI
Advertisement

Upexi (UPXI) AI Stock Analysis

Compare
293 Followers

Top Page

UPXI

Upexi

(NASDAQ:UPXI)

Rating:42Neutral
Price Target:
$5.00
▼(-31.97% Downside)
Upexi's overall stock score is heavily influenced by its significant financial challenges, which pose substantial risks. The company's technical analysis indicates a bearish trend, and its valuation does not offer an attractive investment proposition due to persistent losses. The recent private placement offering provides some liquidity, which is a positive factor, but it does not sufficiently offset the core financial and operational difficulties.

Upexi (UPXI) vs. SPDR S&P 500 ETF (SPY)

Upexi Business Overview & Revenue Model

Company DescriptionUpexi, Inc. manufacture and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Clearwater, Florida.
How the Company Makes MoneyUpexi generates revenue through a combination of direct-to-consumer sales, digital marketing services, and strategic acquisitions. The company operates multiple e-commerce platforms, where it sells its proprietary consumer products ranging from health and wellness to lifestyle goods. Additionally, Upexi offers digital marketing solutions that help brands optimize their online presence and drive sales. The company also seeks to expand its revenue through strategic partnerships and acquisitions, which allow it to enter new markets and diversify its product offerings. Key factors contributing to its earnings include its robust online sales channels, expertise in digital marketing, and successful integration of acquired businesses.

Upexi Earnings Call Summary

Earnings Call Date:May 16, 2025
(Q2-2024)
|
% Change Since: -23.28%|
Next Earnings Date:Feb 17, 2026
Earnings Call Sentiment Negative
The earnings call highlighted significant operational improvements, particularly in gross margins and brand product sales, along with strategic investments in high-margin areas. However, these positives were overshadowed by a notable decline in overall revenue, adjusted EBITDA, and a net loss from continued operations, indicating financial challenges.
Q2-2024 Updates
Positive Updates
Increased Gross Profit Margins
Gross profit margins increased to 38% in the fiscal second quarter from 31.8% in the prior fiscal first quarter.
Growth in Brand Product Sales
Brand Product sales increased 16.7% sequentially to $7.7 million, with Brand Product sales as a percentage of total revenue rising to 35.1% from 24% in the previous quarter.
Cost Reduction and Operational Efficiency
Consolidation of manufacturing facilities is expected to reduce G&A expenses by approximately $2 million annually, contributing to cost savings of $450,000 to $550,000 per quarter.
Negative Updates
Revenue Decline
Revenue for the fiscal second quarter 2024 decreased to $21.8 million from $26.7 million in the same period the previous year and $27.3 million in the fiscal first quarter 2024.
Decrease in Adjusted EBITDA
Adjusted EBITDA dropped significantly to approximately $29,000 from $557,000 in the same period the previous year and $750,000 in the fiscal first quarter 2024.
Net Loss from Continued Operations
The company reported a net loss from continued operations of $2.4 million for the fiscal second quarter 2024, compared to net income of $2.7 million in the same period the previous year.
Company Guidance
During Upexi, Inc.'s fiscal second quarter 2024 earnings call, CEO Allan Marshall highlighted strategic efforts to enhance profitability despite a sequential decrease in revenue to $21.8 million from $27.3 million in the prior quarter. The company's focus on high-margin Brand Products contributed to an increase in gross profit margins to 38% from 31.8% in the previous quarter. Brand Product sales rose by 16.7% to $7.7 million, comprising 35.1% of total revenue. The company recorded positive adjusted EBITDA despite a net loss of $2.4 million, driven by strategic investments in subscription revenue and cost management, including expected annual savings of $2 million from consolidating manufacturing operations. Upexi aims to bolster growth through continued emphasis on its high-margin brand business, targeting improved gross margins and cash flow.

Upexi Financial Statement Overview

Summary
Upexi is experiencing significant financial difficulties, as evidenced by declining revenues, persistent losses, and high leverage. The income statement, balance sheet, and cash flow statement all reflect substantial financial instability, with negative revenue growth, high debt levels, and insufficient cash flow generation.
Income Statement
35
Negative
Upexi's income statement reveals significant challenges, with negative revenue growth in the TTM compared to prior periods. The gross profit margin has decreased notably, and net profit margins have been consistently negative, indicating persistent losses. EBIT and EBITDA margins are also negative, reflecting operational inefficiencies. The company's financial trajectory shows declining revenue and profitability, posing substantial risks.
Balance Sheet
45
Neutral
Upexi's balance sheet highlights financial instability, with a high debt-to-equity ratio indicating significant leverage. The return on equity is negative due to ongoing losses. The equity ratio has been declining, suggesting weakening financial stability. The company's financial position is constrained, with liabilities outweighing equity, increasing financial risk.
Cash Flow
30
Negative
The cash flow statement shows negative operating cash flow and free cash flow, reflecting cash burn and liquidity issues. The free cash flow to net income ratio is negative, indicating that cash flow generation is insufficient to cover losses. Operating cash flow has not been sufficient to support the company's operations, highlighting potential liquidity challenges.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue26.00M36.44M44.58M24.10M7.41M
Gross Profit12.82M21.02M25.19M11.90M2.57M
EBITDA-9.72M-5.05M-4.36M3.56M-4.23M
Net Income-23.66M-16.93M-2.05M2.98M-5.93M
Balance Sheet
Total Assets23.51M63.80M48.49M27.25M6.40M
Cash, Cash Equivalents and Short-Term Investments661.41K4.49M7.15M14.53M887.52K
Total Debt13.45M26.34M15.27M864.06K2.85M
Total Liabilities17.00M35.96M19.70M6.04M4.22M
Stockholders Equity6.52M28.34M28.73M21.22M225.58K
Cash Flow
Free Cash Flow-1.03M-734.89K-5.63M1.52M-6.09M
Operating Cash Flow-101.38K202.68K521.87K2.94M-4.16M
Investing Cash Flow-3.38M-2.57M-11.61M-1.28M-1.46M
Financing Cash Flow-353.79K-285.33K3.70M11.99M2.82M

Upexi Technical Analysis

Technical Analysis Sentiment
Positive
Last Price7.35
Price Trends
50DMA
6.71
Positive
100DMA
7.35
Negative
200DMA
5.77
Positive
Market Momentum
MACD
0.21
Negative
RSI
57.66
Neutral
STOCH
80.61
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UPXI, the sentiment is Positive. The current price of 7.35 is above the 20-day moving average (MA) of 6.17, above the 50-day MA of 6.71, and above the 200-day MA of 5.77, indicating a bullish trend. The MACD of 0.21 indicates Negative momentum. The RSI at 57.66 is Neutral, neither overbought nor oversold. The STOCH value of 80.61 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for UPXI.

Upexi Risk Analysis

Upexi disclosed 6 risk factors in its most recent earnings report. Upexi reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Upexi Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
60
Neutral
$44.04B1.91-11.93%3.99%2.50%-38.33%
46
Neutral
$4.38M-3359.32%-45.76%80.86%
46
Neutral
$9.72M
45
Neutral
$26.42M-5.32%5.72%-39.22%
42
Neutral
$465.22M-475.54%
$95.55K-126.92%
44
Neutral
$5.28M-45.56%65.97%70.28%
* Communication Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
UPXI
Upexi
7.35
3.57
94.44%
FENG
Phoenix New Media
2.22
-0.84
-27.45%
SLE
Super League Enterprise
3.20
-47.20
-93.65%
KRKR
36Kr Holdings Inc
4.70
-0.51
-9.79%
STBXF
Starbox Group Holdings
0.17
-337.59
-99.95%
ONFO
Onfolio Holdings, Inc.
1.04
0.09
9.47%

Upexi Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
Upexi Completes $50M Private Placement Offering
Positive
Jul 16, 2025

On July 14, 2025, Upexi, Inc. completed a private placement equity offering, raising $50 million in gross proceeds. The company plans to allocate approximately $3 million from the net proceeds to support its existing business operations and general corporate purposes, with the remainder funding its Solana treasury strategy. A.G.P/Alliance Global Partners acted as the sole placement agent, and the offering was conducted under certain securities exemptions. The company also entered into agreements to restrict further stock issuance for specified periods post-offering.

The most recent analyst rating on (UPXI) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Upexi stock, see the UPXI Stock Forecast page.

Executive/Board ChangesShareholder Meetings
Upexi Holds 2025 Annual Stockholders Meeting
Neutral
Jun 20, 2025

On June 16, 2025, Upexi, Inc. held its 2025 Annual Meeting of stockholders where several key decisions were made. Stockholders elected the company’s nominees for director, approved the re-domiciling of the company as a Delaware Corporation, increased the number of shares in the Stock Option Plan to 10,000,000, approved executive compensation, set the frequency of advisory votes on executive compensation to every three years, and ratified GBQ Partners LLC as the independent registered public accountant for the fiscal year 2025.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 30, 2025